CRISPR Therapeutics AG
CRSP· Nasdaq
CRISPR Therapeutics AG
- Last sale
- Oct 2, 2026 · -0.07%
- Market cap
- $5.36B
- 96.69M shares
- Filings
- 863
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $3,510,000 | reported | |
| FY 2024 | 2024-12-31 | $37,314,000 | reported | |
| FY 2023 | 2023-12-31 | $371,206,000 | reported | |
| FY 2022 | 2022-12-31 | $1,198,000 | reported | |
| FY 2021 | 2021-12-31 | $914,963,000 | reported | |
| FY 2020 | 2020-12-31 | $719,000 | reported | |
| FY 2019 | 2019-12-31 | $289,590,000 | reported | |
| FY 2018 | 2018-12-31 | $3,124,000 | reported | |
| FY 2017 | 2017-12-31 | $40,997,000 | reported | |
| FY 2016 | 2016-12-31 | $5,164,000 | reported | |
| FY 2015 | 2015-12-31 | $247,000 | reported |
CRISPR Therapeutics AG · CIK 1674416 · Engraved from SEC EDGAR
